CAF to the Rescue! Potential and Challenges of Combination Antifungal Therapy for Reducing Morbidity and Mortality in...

Area of Science:

• Mycology
• Infectious Diseases
• Pharmacology

Background:

• Invasive fungal diseases (IFDs) pose a significant global health challenge.
• Combination antifungal therapy (CAF) offers potential benefits like reduced resistance and improved clearance but faces concerns regarding cost, toxicity, and drug interactions.
• Current guidelines favor antifungal monotherapy due to a lack of robust clinical trial data comparing CAF with monotherapy.

Purpose of the Study:

• To systematically review existing clinical studies on CAF for major IFDs.
• To summarize findings from animal models investigating CAF efficacy.
• To assess laboratory methods for evaluating CAF effectiveness and guide future research priorities.

Main Methods:

• Systematic review of clinical trials involving CAF for invasive candidiasis, cryptococcosis, invasive aspergillosis, and mucormycosis.
• Summary of relevant data from animal models of CAF.
• Assessment of laboratory techniques for determining CAF efficacy.

Main Results:

• The current body of evidence for CAF in IFDs is limited, with a lack of comparative randomized clinical trials.
• Animal models and laboratory assessments provide insights into potential CAF benefits and mechanisms.
• Observational data and animal model survival studies suggest areas for prioritizing future clinical investigations.

Conclusions:

• Further research is needed to establish the role of CAF in managing IFDs.
• Future clinical trials should be informed by promising results from animal models and observational studies.
• Prioritization of CAF trials should focus on agents demonstrating improved survival, efficacy, and safety profiles.